Dr. Patrick Kerzic is a board-certified toxicologist (DABT) with extensive experience in the design, conduct, and analysis of mechanistic and human subject research studies as well as human health risk assessment. Dr. Kerzic completed his PhD in Toxicology at the University of Colorado Health Sciences Center and post-doctoral training at Johns Hopkins University School of Medicine. His doctoral research examined the effects of benzene metabolites on signaling molecules, and their ability to alter survival and differentiation in bone marrow cells. 

Prior to coming to CTEH, Dr. Kerzic served as a Staff Toxicologist with the California Environmental Protection Agency, where he oversaw human health risk assessment activities for over 100 sites contaminated with solvents, metals, and other hazardous materials. He also served as a writer and reviewer for the Safer Consumer Products program, which aims to encourage substitution of hazardous compounds with safer alternatives. 

Dr. Kerzic has served as Scientific Director for a laboratory conducting research and clinical studies into diseases of the blood including leukemia and lymphoma, where he oversaw molecular biology and toxicology programs. 

Throughout his career, Dr. Kerzic has provided technical and litigation support for a variety of projects including court cases involving benzene and other solvents, and assistance to companies and industry associations facing challenges regarding potential hazards caused by their products. He has published more than 35 abstracts and peer-reviewed papers in the fields of toxicology and hematology, and is a past or current member of the American Society of Hematology, the International Society for Experimental Hematology and Stem Cells, and the Society of Toxicology.